High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial
In contrast to resource-rich countries, most HIV-infected patients in resource-limited countries receive treatment without virological monitoring. There are few long-term data, in this setting, on rates of viral suppression or switch to second-line antiretroviral therapy. The DART trial compared cli...
Principais autores: | Kityo, C, Gibb, D, Gilks, C, Goodall, R, Mambule, I, Kaleebu, P, Pillay, D, Kasirye, R, Mugyenyi, P, Walker, A, Dunn, D |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Public Library of Science
2014
|
Registros relacionados
-
High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.
por: Cissy Kityo, et al.
Publicado em: (2014-01-01) -
DART and laboratory monitoring of HIV treatment Reply
por: Walker, A, et al.
Publicado em: (2010) -
Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).
por: Gilks, C, et al.
Publicado em: (2012) -
Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study.
por: Gomo, Z, et al.
Publicado em: (2014) -
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
por: Mugyenyi, P, et al.
Publicado em: (2010)